Master Course in Heart Failure 2026 - Skopje
-
City
Skopje, North Macedonia
Type of event
on site
Save the Date
Master Course in Heart Failure Skopje
Skopje, North Macedonia, 17.-19.09.2026
Directors:
Jorgo Kostov, MD, FESC, Skopje
Tanja Anguseva, MD, FESC, Skopje
Irena Mitevska, MD FESC, Skopje
Thomas F. Lüscher, MD, FRCP, FESC, London
Scientific Coordinator: Christine Lohmann, Zurich
Venue: Hotel Double Tree by Hilton Skopje
Preliminary Programme
Day 1, Thursday September 17th, 2026
| 10:00-12:00 | Session 1: Heart Failure: Update on the 2026 ESC Guidelines Chairs: | |
| 10:00 | Welcome by Course Directors | |
| 10:10 | Learning outcomes | |
| 10:40 | 2026 ESC Guidelines on Cardiovascular disease and chronic kidney disease | |
| 11:00 | 2026 ESC Guidelines on Cardiac Rehabilitation | |
| 11:20 | 2026 ESC Guidelines on 5th Universal definition of myocardial infarction | |
| 11:30 | Panel discussion | |
| 12:00-12:30 | Keynote Lecture: AI/ML in cardiovascular disease | |
| 12:30-13:15 | LUNCH | |
| 13:15-14:30 | Case-based Interactive Learning – Imaging of HF (Breakout Sessions in three groups) | |
| Advanced Echocardiography in HF | ||
| Assessment of congestion by ultrasound diagnostics | ||
| Stress echocardiography in coronary and non-coronary conditions | ||
| 14:30-15:45 | Session 2: Assessing and Diagnosing Heart Failure Chairs: | |
| 14:00 | Clinical assessment of HF | |
| 14:20 | Challenges in the diagnosis of heart failure ECG | |
| 14:40 | Ergo spirometry in diagnosis of HF | |
| 15:00 | F.O.C.U.S. | |
| 15:20 | Differential diagnosis of cardiomyopathies | |
| 15:40 | Panel discussion | |
| 15:55-16:15 | COFFEE BREAK | |
| 16:15-18:30 | Session 3: Cardio-oncology Chairs: | |
| 16:15 | The size of the problem | |
| 16:35 | The ESC Guidelines on Cardio-oncology: what happened since? | |
| 16:55 | Cardiotoxicity in heart failure | |
| 17:15 | Amyloid heart disease | |
| 17:35 | Panel discussion | |
| 18:30 | Welcome Reception, Macedonian Chamber of Commerce session, Get Together | |
Day 2, Friday September 18th, 2026
| 09:00-11:10 | Session 4: The Cardiometabolic Syndrome Chairs: | |
| 09:00 | Obesity and heart failure: effects of GLP-1 agonists | |
| 09:20 | Diabetes and heart failure: effects of SGLT-2i | |
| 09:40 | CKD and cardiovascular risk: assessment and management | |
| 10:00 | Hypertension: Lifestyle, medication or intervention? The 2024 ESC and ESH Guidelines | |
| 10:20 | LDL-C and Lipoprotein (a): novel therapeutic options | |
| 10:40 | Panel discussion | |
| 11:00-11:30 | COFFEE BREAK | |
| 11:30-13:15 | Session 5: Arrhythmias and Cardiomyopathies Chairs: | |
| 11:30 | Atrial fibrillation in HF: epidemiology and prognosis | |
| 11:50 | Patient selection for CRT-D or CRT-P: the 2024 ESC Guidelines | |
| 12:10 | Catheter ablation of Afib: radiofrequency, cooling or PFA? | |
| 12:30 | Current management of hypertrophic cardiomyopathy: devices and/or medication? | |
| 12:50 | Panel discussion | |
| 13:15-14:00 | LUNCH | |
| 14:00-15:15 | Case-based Interactive Learning (Breakout Sessions in three groups) | |
| Advanced Echocardiography in HF | ||
| Assessment of congestion by ultrasound diagnostics | ||
| Stress echocardiography in coronary and non-coronary conditions | ||
| 15:15-15:45 | COFFEE BREAK | |
| 15:30-17:30 | Session 6: Valvular Heart Disease Chairs: | |
| 15:45 | The 2025 ESC Guidelines on valvular heart disease | |
| 16:05 | Multimodality imaging before, during and after valvular interventions | |
| 16:25 | TEER for mitral and tricuspid regurgitation | |
| 16:45 | Ultrasound diagnostics in aortic valvular disease | |
| 17:05 | Panel discussion | |
| 17:15-17:30 | COFFEE BREAK | |
| 17:30-18:45 | Session 7: Pulmonary hypertension and HF Chairs: | |
| 17:30 | Pulmonary hypertension in HF | |
| 17:50 | How do we treat PAH, when do we need triple therapy | |
| 18:10 | Balon pulmonary angioplasty -state of the art | |
| 18:30 | Panel discussion | |
Day 3, Saturday September 19th, 2026
| 09:00-10:45 | Session 8: Interventions in Heart Failure Chair: | |
| 09:00 | PCI works in ischemic cardiomyopathy in selected patients | |
| 09:20 | Medication is better than PCI in ischemic cardiomyopathy | |
| 09:40 | Micro axial pump, ECMO or LVAD in acute HF | |
| 10:00 | Cardiogenic shock after acute myocardial infarction: current management and prognosis | |
| 10:20 | Panel discussion | |
| 10:45-11:15 | COFFEE BREAK | |
| 11:15-12:30 | Case-based Interactive Learning (Breakout Sessions in three groups) | |
| Advanced Echocardiography in HF | ||
| Assessment of congestion by ultrasound diagnostics | ||
| Stress echocardiography in coronary and non-coronary conditions | ||
| 12:45-13:00 | Closing Session | |
| Wrap-up and Adjourn | ||
| 13:00 | LUNCH | |
*The programme might be subject to change.
General Infomation
Registration
Detailed information and registration link to follow soon!
Venue
Hotel ,,DoubleTree” by Hilton, Skopje
Blvd ASNOM 17, Skopje, North Macedonia
Under the auspices of
